{"id":"https://openalex.org/W2889634640","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5034","title":"Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): An analysis from the phase 3 SPARTAN trial.","display_name":"Predicting disease progression in patients (pts) with nonmetastatic castration-resistant prostate cancer (nmCRPC): An analysis from the phase 3 SPARTAN trial.","publication_year":2018,"publication_date":"2018-05-20","ids":{"openalex":"https://openalex.org/W2889634640","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5034","mag":"2889634640"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2018.36.15_suppl.5034","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5034","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.5034","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5007578304","display_name":"Eric Jay Small","orcid":"https://orcid.org/0000-0003-3191-6268","observed_orcids":["https://orcid.org/0000-0003-3191-6268"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eric Jay Small","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA;","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053749991","display_name":"Fred Saad C","orcid":"https://orcid.org/0000-0003-2986-5617","observed_orcids":["https://orcid.org/0000-0003-2986-5617"]},"institutions":[{"id":"https://openalex.org/I4210142730","display_name":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0410a8y51","country_code":"CA","type":"healthcare","lineage":["https://openalex.org/I2801902503","https://openalex.org/I4210139015","https://openalex.org/I4210142730","https://openalex.org/I4405279980"]},{"id":"https://openalex.org/I70931966","display_name":"Universit\u00e9 de Montr\u00e9al","ror":"https://ror.org/0161xgx34","country_code":"CA","type":"education","lineage":["https://openalex.org/I70931966"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Fred Saad","raw_affiliation_strings":["Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al/CRCHUM, University of Montr\u00e9al, Montr\u00e9al, QC, Canada;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre Hospitalier de l\u2019Universit\u00e9 de Montr\u00e9al/CRCHUM, University of Montr\u00e9al, Montr\u00e9al, QC, Canada;","institution_ids":["https://openalex.org/I4210142730","https://openalex.org/I70931966"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002358672","display_name":"Dana E. Rathkopf","orcid":"https://orcid.org/0000-0002-4503-7582","observed_orcids":["https://orcid.org/0000-0002-4503-7582"]},"institutions":[{"id":"https://openalex.org/I1334819555","display_name":"Memorial Sloan Kettering Cancer Center","ror":"https://ror.org/02yrq0923","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1334819555"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dana E. Rathkopf","raw_affiliation_strings":["Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY;","institution_ids":["https://openalex.org/I1334819555"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077243123","display_name":"Boris Alexander Hadaschik","orcid":"https://orcid.org/0000-0002-1052-2692","observed_orcids":["https://orcid.org/0000-0002-1052-2692"]},"institutions":[{"id":"https://openalex.org/I62318514","display_name":"University of Duisburg-Essen","ror":"https://ror.org/04mz5ra38","country_code":"DE","type":"education","lineage":["https://openalex.org/I62318514"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Boris A. Hadaschik","raw_affiliation_strings":["University of Duisburg-Essen, Essen, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Duisburg-Essen, Essen, Germany;","institution_ids":["https://openalex.org/I62318514"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110735930","display_name":"Simon Chowdhury","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1324925910","display_name":"St Thomas' Hospital","ror":"https://ror.org/054gk2851","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I1324925910","https://openalex.org/I200166805","https://openalex.org/I4210111135"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Simon Chowdhury","raw_affiliation_strings":["Guy's, King's and St Thomas' Hospitals, London, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Guy's, King's and St Thomas' Hospitals, London, United Kingdom;","institution_ids":["https://openalex.org/I1324925910"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103094893","display_name":"Margaret K. Yu","orcid":"https://orcid.org/0009-0003-1697-3595","observed_orcids":["https://orcid.org/0009-0003-1697-3595","https://orcid.org/0000-0002-3650-2788"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Margaret K. Yu","raw_affiliation_strings":["Janssen Research &amp; Development, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research &amp; Development, Los Angeles, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020669411","display_name":"Angela Mennicke Lopez- Gitlitz","orcid":"https://orcid.org/0000-0003-3323-7605","observed_orcids":["https://orcid.org/0000-0003-3323-7605"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Angela Lopez-Gitlitz","raw_affiliation_strings":["Janssen Research &amp; Development, Los Angeles, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research &amp; Development, Los Angeles, CA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005905056","display_name":"Oliver Brendan Rooney","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210118116","display_name":"Janssen (United Kingdom)","ror":"https://ror.org/02nw6hx08","country_code":"GB","type":"company","lineage":["https://openalex.org/I1330063522","https://openalex.org/I4210118116"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Oliver Brendan Rooney","raw_affiliation_strings":["Janssen Research &amp; Development, High Wycombe, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research &amp; Development, High Wycombe, United Kingdom;","institution_ids":["https://openalex.org/I4210118116"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103799188","display_name":"Youyi Shu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Youyi Shu","raw_affiliation_strings":["Janssen Research &amp; Development, Collegeville, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research &amp; Development, Collegeville, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009665309","display_name":"Mohamed Darif","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mohamed Darif","raw_affiliation_strings":["Janssen Research &amp; Development, San Diego, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research &amp; Development, San Diego, CA;","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101519988","display_name":"Matthew Raymond Smith","orcid":"https://orcid.org/0000-0001-5207-2370","observed_orcids":["https://orcid.org/0000-0001-5207-2370"]},"institutions":[{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210087915","display_name":"Massachusetts General Hospital","ror":"https://ror.org/002pd6e78","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210087915","https://openalex.org/I48633490"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Raymond Smith","raw_affiliation_strings":["Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Massachusetts General Hospital Cancer Center and Harvard Medical School, Boston, MA;","institution_ids":["https://openalex.org/I136199984","https://openalex.org/I4210087915"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":10,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":4,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"36","issue":"15_suppl","first_page":"5034","last_page":"5034"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10543","display_name":"Prostate Cancer Treatment and Research","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10124","display_name":"Prostate Cancer Diagnosis and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2748","display_name":"Urology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonmetastatic-castration-resistant-prostate-cancer","display_name":"non-metastatic castration-resistant prostate cancer","score":0.9739999771118164},{"id":"https://openalex.org/keywords/apalutamide","display_name":"apalutamide","score":0.9449999928474426},{"id":"https://openalex.org/keywords/spartan-trial","display_name":"SPARTAN trial","score":0.843999981880188},{"id":"https://openalex.org/keywords/metastasis-free-survival","display_name":"metastasis-free survival","score":0.9070000052452087},{"id":"https://openalex.org/keywords/psa-doubling-time","display_name":"PSA doubling time","score":0.8610000014305115},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8019999861717224},{"id":"https://openalex.org/keywords/androgen-receptor-antagonists","display_name":"androgen receptor antagonists","score":0.8830000162124634},{"id":"https://openalex.org/keywords/gleason-score","display_name":"Gleason score","score":0.7910000085830688},{"id":"https://openalex.org/keywords/baseline-psa","display_name":"baseline PSA","score":0.796999990940094},{"id":"https://openalex.org/keywords/lymph-node-status","display_name":"lymph node status","score":0.6600000262260437},{"id":"https://openalex.org/keywords/time-to-metastasis","display_name":"time to metastasis","score":0.8399999737739563},{"id":"https://openalex.org/keywords/risk-prediction-model","display_name":"risk prediction model","score":0.46799999475479126},{"id":"https://openalex.org/keywords/ecog-performance-status","display_name":"ECOG performance status","score":0.9039999842643738}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8787579536437988},{"id":"https://openalex.org/C2780192828","wikidata":"https://www.wikidata.org/wiki/Q181257","display_name":"Prostate cancer","level":3,"score":0.7085984945297241},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5863327383995056},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.5683212876319885},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5401059985160828},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.4495472013950348},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.43750476837158203},{"id":"https://openalex.org/C38180746","wikidata":"https://www.wikidata.org/wiki/Q1952580","display_name":"Multivariate analysis","level":2,"score":0.42726486921310425},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4220670163631439},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.4136753976345062},{"id":"https://openalex.org/C2781406297","wikidata":"https://www.wikidata.org/wiki/Q409450","display_name":"Prostate-specific antigen","level":4,"score":0.4111623764038086},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3753405809402466},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34690162539482117},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2018.36.15_suppl.5034","doi":"https://doi.org/10.1200/jco.2018.36.15_suppl.5034","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2018.36.15_suppl.5034","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2789521745","https://openalex.org/W2891700365","https://openalex.org/W3030001291","https://openalex.org/W4324136380","https://openalex.org/W2978738441","https://openalex.org/W2793094876","https://openalex.org/W2901774432","https://openalex.org/W2947444428","https://openalex.org/W4324137102","https://openalex.org/W2886013459"],"abstract_inverted_index":{"5034":[0],"Background:":[1],"Men":[2],"with":[3,43,198,214],"nmCRPC":[4,44,199],"and":[5,22,83,113,125,159,171,188,241],"prostate-specific":[6],"antigen":[7],"doubling":[8],"time":[9,173,242],"(PSADT)":[10],"of":[11,65,79,91,138,194,205,218,228,326],"\u2264":[12,157,162,266,282,300],"10":[13,310],"mo":[14,280,284],"are":[15],"at":[16,97,155,298,317],"high":[17],"risk":[18,219],"for":[19,141,212,221],"metastatic":[20],"disease":[21],"associated":[23],"death.":[24,246],"Apalutamide":[25],"(APA),":[26],"a":[27,215,236],"next-generation":[28],"androgen":[29],"receptor":[30],"inhibitor,":[31],"extended":[32],"metastasis-free":[33],"survival":[34],"(MFS)":[35],"by":[36],"median":[37],">":[38,148,270,278],"2":[39,340],"years":[40,311],"in":[41,53,67,196,223],"men":[42],"(HR":[45],"[95%":[46],"CI]":[47],"0.28":[48],"[0.23-0.35];":[49],"p":[50,254],"<":[51,262,275],"0.0001)":[52],"SPARTAN.":[54,201],"A":[55,72,166],"multivariate":[56],"analysis":[57],"(MVA)":[58],"was":[59,129,178],"undertaken":[60],"to":[61,174,226,243],"identify":[62],"independent":[63,136,192],"predictors":[64,78,137,193],"MFS":[66,140,195,222],"this":[68],"pt":[69],"population.":[70],"Methods:":[71],"nonstratified":[73],"proportional":[74],"hazards":[75],"model":[76],"assessed":[77],"clinical":[80],"end":[81],"points":[82],"examined":[84],"the":[85,126,142,224,229],"following":[86,132],"covariates:":[87],"treatment,":[88,146,182],"PSADT,":[89,183,277],"use":[90],"bone-sparing":[92,327],"agents,":[93],"N0":[94,151,290],"vs":[95,258,269,281,291,302,320,330,341],"N1":[96,292],"study":[98],"entry,":[99],"Eastern":[100],"Cooperative":[101],"Oncology":[102],"Group":[103],"performance":[104],"status":[105],"(ECOG":[106],"PS),":[107],"prior":[108],"therapies,":[109],"Gleason":[110,153,186,296],"score,":[111,187],"age,":[112],"baseline":[114,160,189],"PSA.":[115],"Results:":[116],"1207":[117],"pts":[118,197],"were":[119,191],"randomized":[120],"(806,":[121],"APA;":[122],"401,":[123],"PBO),":[124],"overall":[127],"population":[128],"evaluated.":[130],"The":[131,202],"covariates":[133],"emerged":[134],"as":[135],"longer":[139],"combined":[143],"arms:":[144],"APA":[145,181,206,257],"PSADT":[147,170,240],"6":[149,279,283],"mo,":[150],"disease,":[152,185,289],"score":[154,297],"diagnosis":[156],"7,":[158],"PSA":[161,190],"7.8":[163,267,271],"ng/mL":[164,268,272],"(Table).":[165],"relationship":[167,238],"between":[168,239],"shorter":[169],"faster":[172],"metastasis":[175,244],"or":[176,245],"death":[177],"observed.":[179],"Conclusions:":[180],"nodal":[184],"from":[200],"treatment":[203],"effect":[204],"remained":[207],"highly":[208],"significant":[209],"after":[210],"adjusting":[211],"covariates,":[213],"similar":[216],"magnitude":[217],"reduction":[220],"MVA":[225],"that":[227],"original":[230],"primary":[231],"analysis.":[232],"Furthermore,":[233],"there":[234],"is":[235],"continuous":[237],"Clinical":[247],"trial":[248],"information:":[249],"NCT01946204.Covariate":[250],"HR":[251],"(95%":[252],"CI)":[253],"Value":[255],"Treatment,":[256],"PBO":[259],"0.26":[260],"(0.21-0.32)":[261],"0.0001":[263,276],"Baseline":[264],"PSA,":[265],"0.59":[273],"(0.47-0.73)":[274],"0.65":[285],"(0.51-0.84)":[286],"0.0007":[287],"Loco-regional":[288],"0.68":[293],"(0.52-0.89)":[294],"0.0055":[295],"diagnosis,":[299],"7":[301],"\u2265":[303,339],"8":[304],"0.75":[305],"(0.61-0.92)":[306],"0.0063":[307],"Age":[308],"per":[309],"0.88":[312],"(0.77-1.01)":[313],"0.0784":[314],"ECOG":[315],"PS":[316],"baseline,":[318],"0":[319],"1":[321,342],"0.84":[322],"(0.66-1.07)":[323],"0.154":[324],"Use":[325],"agent,":[328],"yes":[329],"no":[331],"0.78":[332],"(0.55-1.12)":[333],"0.174":[334],"Prior":[335],"hormonal":[336],"therapies;":[337],"n,":[338],"0.90":[343],"(0.69-1.16)":[344],"0.406":[345]},"counts_by_year":[{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2}],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2018-09-27T00:00:00"}
